{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:19:44Z","timestamp":1790882384721,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clnesp.2026.103288","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T17:42:08Z","timestamp":1776015728000},"page":"103288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Albumin-myosteatosis gauge as predictor of survival time in patients with lung cancer treated with immune checkpoint inhibitors"],"prefix":"10.1016","volume":"73","author":[{"given":"Lai","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-5762","authenticated-orcid":false,"given":"Xin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2026.103288_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102693","article-title":"Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN","volume":"93","author":"Zhou","year":"2024","journal-title":"Cancer Epidemiol"},{"issue":"10125","key":"10.1016\/j.clnesp.2026.103288_bib2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103288_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4143\/crt.2022.264","article-title":"Five-year overall survival and prognostic factors in patients with lung cancer: results from the Korean association of lung cancer registry (KALC-R) 2015","volume":"55","author":"Jeon","year":"2023","journal-title":"Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103288_bib4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.21037\/tlcr-22-240","article-title":"Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China","volume":"11","author":"He","year":"2022","journal-title":"Transl Lung Cancer Res"},{"issue":"7","key":"10.1016\/j.clnesp.2026.103288_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1200\/JCO.20.01605","article-title":"Five-year outcomes from the randomized, phase III trials CheckMate 017 and 057: nivolumab versus docetaxel in previously treated non-small-cell lung cancer","volume":"39","author":"Borghaei","year":"2021","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103288_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccell.2023.12.013","article-title":"Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer","volume":"42","author":"Memon","year":"2024","journal-title":"Cancer Cell"},{"issue":"Suppl 3","key":"10.1016\/j.clnesp.2026.103288_bib7","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.21037\/tlcr.2018.08.09","article-title":"Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy","volume":"7","author":"Malapelle","year":"2018","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"10.1016\/j.clnesp.2026.103288_bib8","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.21037\/qims-24-365","article-title":"Myosteatosis: diagnostic significance and assessment by imaging approaches","volume":"14","author":"Garcia-Diez","year":"2024","journal-title":"Quant Imag Med Surg"},{"key":"10.1016\/j.clnesp.2026.103288_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101398","article-title":"Updated systematic review and meta-analysis on diagnostic issues and the prognostic impact of myosteatosis: a new paradigm beyond sarcopenia","volume":"70","author":"Ahn","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103288_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/ajt.15577","article-title":"Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation","volume":"20","author":"Czigany","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103288_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64420-x","article-title":"Association of myosteatosis with short-term outcomes in patients with acute-on-chronic liver failure","volume":"14","author":"Geng","year":"2024","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.clnesp.2026.103288_bib12","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/ibd\/izad225","article-title":"Obesity, sarcopenia and myosteatosis: impact on clinical outcomes in the operative management of Crohn\u2019s disease","volume":"30","author":"Donnelly","year":"2024","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.clnesp.2026.103288_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0310017","article-title":"Myosteatosis and the clinical outcomes of patients with liver cirrhosis: a meta-analysis","volume":"19","author":"Xue","year":"2024","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103288_bib14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41430-025-01566-5","article-title":"Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy","volume":"79","author":"Perrier","year":"2025","journal-title":"Eur J Clin Nutr"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103288_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3748\/wjg.v30.i8.863","article-title":"Evaluating the influence of sarcopenia and myosteatosis on clinical outcomes in gastric cancer patients undergoing immune checkpoint inhibitor","volume":"30","author":"Deng","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.clnesp.2026.103288_bib16","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s00595-025-03058-2","article-title":"The albumin-myosteatosis gauge predicts the response to neoadjuvant chemotherapy for locally advanced gastric cancer","volume":"55","author":"Huang","year":"2025","journal-title":"Surg Today"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103288_bib17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s10147-024-02512-4","article-title":"Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy","volume":"29","author":"Sahin","year":"2024","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103288_bib18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/jcsm.13183","article-title":"Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer","volume":"14","author":"Kim","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103288_bib19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/ueg2.12627","article-title":"Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: a subanalysis of the SORAMIC trial","volume":"12","author":"Surov","year":"2024","journal-title":"United Eur Gastroenterol J"},{"issue":"9","key":"10.1016\/j.clnesp.2026.103288_bib20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/1750743X.2025.2525743","article-title":"Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors","volume":"17","author":"Sahin","year":"2025","journal-title":"Immunotherapy"},{"issue":"12","key":"10.1016\/j.clnesp.2026.103288_bib21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clnesp.2026.103288_bib22","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/jcsm.12575","article-title":"Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis","volume":"11","author":"Lee","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2026.103288_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s00595-025-03058-2","article-title":"The albumin-myosteatosis gauge predicts the response to neoadjuvant chemotherapy for locally advanced gastric cancer","author":"Huang","year":"2025","journal-title":"Surg Today"},{"key":"10.1016\/j.clnesp.2026.103288_bib24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ijbiomac.2021.06.140","article-title":"Serum albumin levels and inflammation","volume":"184","author":"Sheinenzon","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.clnesp.2026.103288_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40364-017-0111-x","article-title":"Critical appraisal of the role of serum albumin in cardiovascular disease","volume":"5","author":"Chien","year":"2017","journal-title":"Biomark Res"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103288_bib26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1186\/s40001-025-02925-5","article-title":"Dynamic association of serum albumin changes with inflammation, nutritional status and clinical outcomes: a secondary analysis of a large prospective observational cohort study","volume":"30","author":"Li","year":"2025","journal-title":"Eur J Med Res"},{"issue":"8","key":"10.1016\/j.clnesp.2026.103288_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/nu9080829","article-title":"Evaluation of blood biomarkers associated with risk of malnutrition in older adults: a systematic review and meta-analysis","volume":"9","author":"Zhang","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103288_bib28","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1186\/s12885-024-12872-9","article-title":"The controlling nutritional status score as a new prognostic predictor in patients with cervical cancer receiving radiotherapy: a propensity score matching analysis","volume":"24","author":"Fu","year":"2024","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.clnesp.2026.103288_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/nu13061980","article-title":"The spectrum of Malnutrition\/Cachexia\/Sarcopenia in oncology according to different cancer types and settings: a narrative review","volume":"13","author":"Bossi","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2026.103288_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.clnesp.2026.103288_bib31","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.1093\/nutrit\/nuae094","article-title":"Skeletal muscle index-based Cachexia Index as a predictor of prognosis in patients with cancer: a meta-analysis and systematic review","volume":"83","author":"Xu","year":"2025","journal-title":"Nutr Rev"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103288_bib32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ncp.70032","article-title":"The cachexia index as a prognostic indicator in patients with cervical cancer treated with radiotherapy: a retrospective study","volume":"41","author":"Tian","year":"2026","journal-title":"Nutr Clin Pract"},{"issue":"12","key":"10.1016\/j.clnesp.2026.103288_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.clnu.2024.10.017","article-title":"The prognostic value of myosteatosis in pancreatic cancer: a systematic review and meta-analysis","volume":"43","author":"Chen","year":"2024","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103288_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jcsm.12901","article-title":"Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review","volume":"13","author":"Li","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2026.103288_bib35","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3389\/fphys.2020.00963","article-title":"Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging","volume":"11","author":"Correa-de-Araujo","year":"2020","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.clnesp.2026.103288_bib36","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1186\/s12885-022-09752-5","article-title":"Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study","volume":"22","author":"Ruan","year":"2022","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.clnesp.2026.103288_bib37","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10147-022-02181-1","article-title":"Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis","volume":"27","author":"Feng","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clnesp.2026.103288_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102839","article-title":"Myosteatosis and prognosis in cancer: systematic review and meta-analysis","volume":"145","author":"Aleixo","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.clnesp.2026.103288_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/01635581.2022.2153879","article-title":"Sarcopenia as a determinant of the efficacy of immune checkpoint inhibitors in non-small cell lung cancer: a meta-analysis","volume":"75","author":"Ren","year":"2023","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.clnesp.2026.103288_bib40","article-title":"Prognostic impact of Sarcopenia on clinical outcomes in malignancies treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726003840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457726003840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:32:47Z","timestamp":1779413567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457726003840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S2405457726003840"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103288","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Albumin-myosteatosis gauge as predictor of survival time in patients with lung cancer treated with immune checkpoint inhibitors","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2026.103288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103288"}}